These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 29446148)

  • 1. Efficacy of low-dose 5-fluorouracil/cisplatin therapy for invasive extramammary Paget's disease.
    Kato H; Watanabe S; Kariya K; Nakamura M; Morita A
    J Dermatol; 2018 May; 45(5):560-563. PubMed ID: 29446148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trial of low-dose 5-fluorouracil/cisplatin therapy for advanced extramammary Paget's disease.
    Kariya K; Tsuji T; Schwartz RA
    Dermatol Surg; 2004 Feb; 30(2 Pt 2):341-4. PubMed ID: 14871231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose 5-fluorouracil/cisplatin therapy as conversion chemotherapy for advanced extramammary Paget's disease.
    Nakamura K; Nakamura M; Kato H; Morita A
    Kaohsiung J Med Sci; 2020 Apr; 36(4):287-288. PubMed ID: 31868989
    [No Abstract]   [Full Text] [Related]  

  • 4. Modified weekly regimen of cisplatin, epirubicin and paclitaxel induced a durable response in two cases of metastatic extramammary Paget's disease.
    Hirai I; Funakoshi T
    J Dermatol; 2017 Oct; 44(10):1148-1151. PubMed ID: 28406527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination chemotherapy of low-dose 5-fluorouracil and cisplatin for advanced extramammary Paget's disease.
    Tokuda Y; Arakura F; Uhara H
    Int J Clin Oncol; 2015 Feb; 20(1):194-7. PubMed ID: 24687531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Docetaxel Combined With Cisplatin for Metastatic Extramammary Paget Disease.
    Cai H; Xu W; Yu B; Li X; Zhu L; Xu Z; Zhou J; Zheng Y; Zou Q; Zeng Y; Wang X; Xu T
    Clin Genitourin Cancer; 2018 Aug; 16(4):e899-e901. PubMed ID: 29685612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of metastatic extramammary Paget's disease that responded to combination chemotherapy.
    Yamazaki N; Yamamoto A; Wada T; Ishikawa M; Moriya Y; Nakanishi Y
    J Dermatol; 1999 May; 26(5):311-6. PubMed ID: 10380432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Docetaxel induced durable response in advanced extramammary Paget's disease: a case report.
    Oguchi S; Kaneko M; Uhara H; Saida T
    J Dermatol; 2002 Jan; 29(1):33-7. PubMed ID: 11837572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Weekly docetaxel monotherapy for metastatic extramammary Paget's disease: Retrospective single-institute analysis.
    Nakamura Y; Tanese K; Hirai I; Fukuda K; Kawakami Y; Amagai M; Funakoshi T
    J Dermatol; 2020 Apr; 47(4):418-422. PubMed ID: 32020662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spontaneous apparent clinical resolution with histologic persistence of a case of extramammary Paget's disease: response to topical 5-fluorouracil.
    Del Castillo LF; Garcia C; Schoendorff C; Garcia JF; Torres LM; Garcia Almagro D
    Cutis; 2000 May; 65(5):331-3. PubMed ID: 10826098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chemotherapy of advanced adenocarcinoma of the skin].
    Yamazaki N
    Gan To Kagaku Ryoho; 1993 Aug; 20(10):1302-7. PubMed ID: 8394060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of docetaxel as first-line chemotherapy for metastatic extramammary Paget's disease.
    Yoshino K; Fujisawa Y; Kiyohara Y; Kadono T; Murata Y; Uhara H; Hatta N; Uchi H; Matsushita S; Takenouchi T; Hayashi T; Ohara K
    J Dermatol; 2016 Jun; 43(6):633-7. PubMed ID: 26603144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological characteristics, management and outcome of metastatic penoscrotal extramammary Paget's disease.
    Zhu Y; Ye DW; Yao XD; Zhang SL; Dai B; Zhang HL; Shen YJ; Mao HR
    Br J Dermatol; 2009 Sep; 161(3):577-82. PubMed ID: 19438449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imiquimod 5% cream as a therapeutic option for extramammary Paget's disease.
    Sawada M; Kato J; Yamashita T; Yoneta A; Hida T; Horimoto K; Sato S; Uhara H
    J Dermatol; 2018 Feb; 45(2):216-219. PubMed ID: 29115681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination Cisplatin-Epirubicin-Paclitaxel Therapy for Metastatic Extramammary Paget's Disease.
    Hirai I; Tanese K; Nakamura Y; Ishii M; Kawakami Y; Funakoshi T
    Oncologist; 2019 Jun; 24(6):e394-e396. PubMed ID: 30846514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination chemotherapy for metastatic extramammary Paget disease.
    Oashi K; Tsutsumida A; Namikawa K; Tanaka R; Omata W; Yamamoto Y; Yamazaki N
    Br J Dermatol; 2014 Jun; 170(6):1354-7. PubMed ID: 24329551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the biomarkers for targeted therapies in primary extra-mammary and mammary Paget's disease.
    Gatalica Z; Vranic S; Krušlin B; Poorman K; Stafford P; Kacerovska D; Senarathne W; Florento E; Contreras E; Leary A; Choi A; In GK
    Cancer Med; 2020 Feb; 9(4):1441-1450. PubMed ID: 31899853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extramammary Paget's disease resistant to surgery and imiquimod monotherapy but responsive to imiquimod combination topical chemotherapy with 5-fluorouracil and retinoic acid: a case report.
    Ye JN; Rhew DC; Yip F; Edelstein L
    Cutis; 2006 Apr; 77(4):245-50. PubMed ID: 16706242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical Combination of Fluorouracil and Calcipotriene as a Palliative Therapy for Refractory Extramammary Paget Disease.
    Molina GE; Khalifian S; Mull JL; Chen L; Rosman IS; Faulkner-Jones BE; Ngo KH; Demehri S; Cornelius LA; Wu PA
    JAMA Dermatol; 2019 May; 155(5):599-603. PubMed ID: 30785593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chemotherapy for advanced adenocarcinoma of the skin: experience with combination chemotherapy and a review of the literature].
    Yamazaki N
    Gan To Kagaku Ryoho; 1997 Jan; 24(1):30-6. PubMed ID: 9020942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.